Equip and Women's Health Release New Research on Diagnostic Delays, Weight Bias and Mental Health Gaps for PMOS Patients
Why now
Thesis: Advocacy research, no market catalyst
Catalyst to watch: Guideline or payer response
Main risk: Survey-based, no commercial link
Why it matters
Research on diagnostic delays raises awareness but lacks commercial or policy catalyst.
Details
Landmark research shows weight stigma, medical dismissal, and overlooked mental health conditions derail Polyendocrine Metabolic Ovarian Syndrome (PMOS) care SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- After the decision earlier this year to rename Polycystic Ovary Syndrome (PCOS) to...
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-24 12:01 UTC